Skip to content
Advancing ATTR-CM Identification: Early Findings from TRACE-AI episode artwork

Sep 3, 2026 4 min

Advancing ATTR-CM Identification: Early Findings from TRACE-AI

from Conference Coverage

Guest: Bruno Batinica, MD Could multimodal AI help identify patients with transthyretin amyloid cardiomyopathy (ATTR-CM) who might otherwise go undiagnosed? Dr. Bruno Batinica, a Postdoctoral Associate at the Yale School of Medicine, joins us to share early findings from the TRACE-AI study, including AI-enabled model performance across diverse health systems, the potential value of combining modalities to improve positive predictive value, and next steps toward prospective deployment in clinical practice.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Advancing ATTR-CM Identification: Early Findings from TRACE-AI

0:00 4:45

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Conference Coverage?

This episode is 4 minutes long.

When was this Conference Coverage episode published?

This episode was published on September 3, 2026.

Can I download this Conference Coverage episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.